Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature.

Tsiogka, Aikaterini; Bauer, Johann W; Patsatsi, Aikaterini

Tsiogka, Aikaterini; Bauer, Johann W; Patsatsi, Aikaterini.

Afiliación

Tsiogka A; Department of Dermatology and Allergology, University Hospital of Paracelsus Medical University, Salzburg, Austria. E-mail: a.tsiogka@yahoo.com.

Acta Derm Venereol ; 101(1): adv00377, 2021 Jan 20.

Article en En | MEDLINE | ID: mdl-33426566

Asunto(s)

Neoplasias; Penfigoide Ampolloso; Humanos; Inmunoterapia/efectos adversos; Ligandos; Penfigoide Ampolloso/inducido químicamente; Penfigoide Ampolloso/diagnóstico; Receptor de Muerte Celular Programada 1

Palabras clave

PD-1 inhibitor; PD-L1 inhibitor; bullous pemphigoid; checkpoint inhibitor; immune-related adverse event; autoimmune bullous disorder

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Penfigoide Ampolloso / Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Acta Derm Venereol Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google